Info@ThinkPinkRocks.com

LCS Therapeutics collaborates to commercialize patent on method to treat binge eating disorder

LCS Therapeutics announced today that it has entered into a strategic collaboration with Lucerne Biosciences, LLC to commercialize U.S. Patent No. 8,318,813 entitled “Method of Treating Binge Eating Disorder.”

Read More:
LCS Therapeutics collaborates to commercialize patent on method to treat binge eating disorder

Share

Leave a Reply